Oral Presentation
Late-breaking studies in asthma and COPD
08:30
Late Breaking Abstract - Efficacy and safety of tezepelumab in adults with severe asthma: A randomized phase 2 study
J. Corren(Los Angeles, United States)
COI
1
08:45
Late Breaking Abstract - The association between dynamic lung function and peak oxygen uptake in a healthy general population. The HUNT Study.
Ø. Rasch-Halvorsen(Trondheim, Norway)
COI
2
09:00
Late Breaking Abstract - Global RSV-associated mortality in young children: a case series.
N. Scheltema(Utrecht, Netherlands)
COI
3
09:15
Late Breaking Abstract - EvA consortium: bronchial brush bacterial load is associated with airway remodelling in mild-to-moderate COPD
M. Yavari Ramsheh(Leicester (Leicestershire), United Kingdom)
COI
4
09:30
Late Breaking Abstract - Effectiveness of Fluticasone furoate/vilanterol (FF/VI) compared to usual care (UC) in patients with asthma: The Salford Lung Study (SLS)
A. Woodcock(Manchester (Greater Manchester), United Kingdom)
COI
5
09:45
Late Breaking Abstract - Mepolizumab reduces exacerbations in eosinophilic COPD
F. Sciurba(Pittsburgh, United States)
COI
6
. . .